Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 9 matching records
TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTIONDepartment of Health and Human Services$2.5M obligationsEnds Dec 31, 2028
NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLEDepartment of Health and Human Services$1.3M obligationsEnds Mar 31, 2028
FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIALDepartment of Health and Human Services$2.2M obligationsEnds Jul 31, 2027
NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLEDepartment of Health and Human Services$1.2M obligationsEnds Oct 31, 2027
STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB)…Department of Health and Human Services$2.3M obligationsEnds Oct 21, 2026
TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019…Department of Health and Human Services$3.6M obligationsEnds Sep 19, 2026
ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RINGDepartment of Health and Human Services$1.2M obligationsEnds Sep 25, 2026
COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTIONDepartment of Health and Human Services$6.4M obligationsEnds Apr 30, 2025
PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTSDepartment of Health and Human Services$994.1K obligationsEnds Sep 24, 2027